secwatch.observer — SEC 8-K summary
======================================

Issuer:     Journey Medical Corp (DERM)
CIK:        0001867066
Form:       8-K
Filed at:   2024-05-01T23:59:59+00:00
Accession:  0001104659-24-055725
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Journey Medical appoints Joseph Benesch as permanent CFO effective April 26
---------------------------------------------------------------------------

- Mr. Benesch had served as interim CFO since January 2023 and as Corporate Controller since November 2021.
- Compensation remains unchanged; any future changes will be determined by Board/Compensation Committee.
- Benesch brings over 25 years of public/private accounting and life sciences experience, including prior CFO roles at Teligent and Torrent.
- CEO Claude Maraoui cited Benesch's leadership as key for upcoming milestones, including potential DFD-29 FDA decision for rosacea.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1867066/000110465924055725/0001104659-24-055725-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1867066/000110465924055725/tm2413228d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-055725

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer